{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:49:33Z","timestamp":1776091773413,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bjid.2021.101573","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T07:55:05Z","timestamp":1617695705000},"page":"101573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-2025","authenticated-orcid":false,"given":"Simone Monzani","family":"Vivaldini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9799-9233","authenticated-orcid":false,"given":"Rachel Abra\u00e3o","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1687-5026","authenticated-orcid":false,"given":"Gl\u00e1ucio","family":"Mosimann J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-8411","authenticated-orcid":false,"given":"Karen Cristine","family":"Tonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8886-1662","authenticated-orcid":false,"given":"Gerson Fernando Mendes","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-021X","authenticated-orcid":false,"given":"Wildo Navegantes de","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2021.101573_bib0005","author":"World Health Organization"},{"key":"10.1016\/j.bjid.2021.101573_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Blach","year":"2017","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.bjid.2021.101573_bib0015","author":"World Health Organization"},{"key":"10.1016\/j.bjid.2021.101573_bib0020","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2021.101573_bib0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bjid.2019.04.010","article-title":"Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach","volume":"23","author":"Benzaken","year":"2019","journal-title":"Braz J Infect Dis."},{"key":"10.1016\/j.bjid.2021.101573_bib0030","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade, Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Hepatite C e Coinfec\u00e7\u00f5es. Bras\u00edlia, 2011."},{"key":"10.1016\/j.bjid.2021.101573_bib0035","series-title":"Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Hepatite C e Coinfec\u00e7\u00f5es","first-page":"1","author":"Minist\u00e9rio da Sa\u00fade-Brasil","year":"2015"},{"key":"10.1016\/j.bjid.2021.101573_bib0040","first-page":"80","article-title":"Impact of direct-acting antiviral therapy for hepatitis C \u2013 related hepatocellular carcinoma","author":"Id","year":"2020","journal-title":"PLoS One J."},{"key":"10.1016\/j.bjid.2021.101573_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0208112","article-title":"Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C","volume":"13","author":"Gallach","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2021.101573_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0217751","article-title":"Treatment with direct-acting antivirals improves peripheral insulin sensitivity in nondiabetic, lean chronic hepatitis C patients","volume":"14","author":"Gastaldi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2021.101573_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0205277","article-title":"Impact of successful treatment with directacting antiviral agents on health-related quality of life in chronic hepatitis C patients","volume":"13","author":"Juanbeltz","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2021.101573_bib0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/liv.13659","article-title":"The impact of treatment of hepatitis C with DAAs on the occurrence of HCC","volume":"38","author":"Roche","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.bjid.2021.101573_bib0065","series-title":"Protocolo Cl\u00ednico E Diretrizes Terap\u00eauticas Para Hepatite C e Coinfec\u00e7\u00f5es","author":"Minist\u00e9rio da Sa\u00fade. B","year":"2018"},{"key":"10.1016\/j.bjid.2021.101573_bib0070","author":"Brasil. Minist\u00e9rio da Sa\u00fade"},{"key":"10.1016\/j.bjid.2021.101573_bib0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1590\/s0004-2803.201800000-74","article-title":"Hepatitis C in the Brazilian public health care system: burden of disease","volume":"55","author":"Castelo","year":"2018","journal-title":"Arq Gastroenterol."},{"key":"10.1016\/j.bjid.2021.101573_bib0080","author":"Departamento de Inform\u00e1tica do SUS\/DATASUS-Minist\u00e9rio da Sa\u00fade"},{"key":"10.1016\/j.bjid.2021.101573_bib0085","author":"R Foundation for Statistical"},{"key":"10.1016\/j.bjid.2021.101573_bib0090","article-title":"Direct-acting antiviral agents in patients with hepatitis C cirrhosis","volume":"8","author":"Im","year":"2012","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.bjid.2021.101573_bib0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jvh.13218","article-title":"Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment","volume":"27","author":"Daniel","year":"2020","journal-title":"J Viral Hepat."},{"key":"10.1016\/j.bjid.2021.101573_bib0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.idc.2017.07.014","article-title":"Hepatitis C virus infection in the older patient","volume":"31","author":"Reid","year":"2017","journal-title":"Infect Dis Clin North Am."},{"key":"10.1016\/j.bjid.2021.101573_bib0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.gastro.2016.05.049","article-title":"Effectiveness of sofosbuvir, ledipasvir\/sofosbuvir, or paritaprevir\/ritonavir\/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the Veterans affairs national health care system","volume":"151","author":"Ioannou","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bjid.2021.101573_bib0110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/MEG.0000000000000858","article-title":"Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients","volume":"29","author":"Su","year":"2017","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.bjid.2021.101573_bib0115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bjid.2018.04.003","article-title":"Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil","volume":"22","author":"Ferreira","year":"2018","journal-title":"Braz J Infect Dis."},{"key":"10.1016\/j.bjid.2021.101573_bib0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bjid.2018.06.004","article-title":"Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil","volume":"22","author":"Holzmann","year":"2018","journal-title":"Braz J Infect Dis."},{"key":"10.1016\/j.bjid.2021.101573_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-017-0676-8","article-title":"Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil","volume":"17","author":"Perazzo","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bjid.2021.101573_bib0130","first-page":"1","article-title":"Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir\/sofosbuvir or simeprevir\/sofosbuvir against GT1 HCV infection","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep."},{"key":"10.1016\/j.bjid.2021.101573_bib0135","first-page":"139","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access","volume":"176","author":"Das","year":"2017","journal-title":"Physiol Behav."},{"key":"10.1016\/j.bjid.2021.101573_bib0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a lancet gastroenterology & hepatology commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol."}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867021000428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867021000428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:57:02Z","timestamp":1761407822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867021000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1413867021000428"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2021.101573","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.06.20207274","asserted-by":"object"}]},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2021.101573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Brasileira de Infectologia.","name":"copyright","label":"Copyright"}],"article-number":"101573"}}